Martin Babler

Martin Babler

Country

United States

Occupation

Business

Description

Chairman, President and Chief Executive Officer of Alumis since 2021. Board member of Prelude Therapeutics, Omega Alpha SPAC, Neoluken Therapeutics, 89Bio, and several other therapeutic companies.

See Also

• LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies

Further Reading/Research

• https://www.linkedin.com/in/martin-babler-33b48/
• https://ir.89bio.com/news-releases/news-release-details/89bio-appoints-biotech-industry-veteran-martin-babler-its-board
• https://www.youtube.com/watch?v=B_y0BqOu5aU

Share on Facebook

Tweet